Evidence map›Paper›PMID 31729760›Full record

ArticleEuropean journal of immunology2020

The multifaceted Foxp3

José Almeida-Santos, Marie-Louise Bergman, Inês Amendoeira Cabral, Vasco Correia, Íris Caramalho, Jocelyne Demengeot

Abstract read
In one paragraph

Article in European journal of immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

José Almeida-SantosInstituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID 0000-0002-6212-3722
Marie-Louise BergmanInstituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID 0000-0003-0691-4308
Inês Amendoeira CabralInstituto Gulbenkian de Ciência, Oeiras, Portugal.
Vasco CorreiaInstituto Gulbenkian de Ciência, Oeiras, Portugal.
Íris CaramalhoInstituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID 0000-0003-2479-7846
Jocelyne DemengeotInstituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID 0000-0002-4761-614X

Funding

FCT, Lisboa2020, Por2020, ERDFPortuguese scientific council (Fundação para a Ciência e a Tecnologia) 283/BI/15Portuguese scientific council (Fundação para a Ciência e a Tecnologia) SFRH/BD/52435/2013Portuguese scientific council (Fundação para a Ciência e a Tecnologia) SFRH/BPD/111454/2015Portuguese scientific council (Fundação para a Ciência e a Tecnologia) UID/Multi/04555/2013
6 · The paper itself

Abstract

It is well established that therapeutic impairment of Foxp3

Indexed as

AllelesAnimalsForkhead Transcription FactorsImmunologic SurveillanceMiceMice, Inbred C57BLNeoplasms, ExperimentalT-Lymphocytes, RegulatoryForkhead Transcription FactorsFoxp3 protein, mouseanti-CTLA4hypomorphregulatory T cells

Identifiers

PMID31729760
PMCPMC7078871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.